undamentalytics Newsletter

Costello Richard A: insider trades

Officer at ICU Medical Inc. No open-market purchases and 19 sales not made under a pre-set plan, reported from February 18, 2010 to February 26, 2014.

What happened after Costello Richard A’s sales?

After their sales, the shares moved +6.3% against the index over 12 months on average (a negative figure means selling was the right call); 37% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Costello Richard A: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 19 −1.1% −2.2% 58% 5 −0.23 0.83 No reliable evidence
Sales, 12 months after the report 19 +6.3% +0.7% 37% 5 1.73 0.16 No reliable evidence
Sales, 12 months after the trade 19 +5.8% +3.4% 37% 5 1.75 0.15 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
ICU Medical Inc ICUI Vice President Sales019February 18, 2010February 26, 2014

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 26, 2014February 25, 2014 ICUI Sale $1,729,674 −0.3%+36.7%+33.4%
November 14, 2013November 14, 2013 ICUI Sale $39,641 −3.8%+21.4%+21.4%
November 4, 2013November 1, 2013 ICUI Sale $1,252,818 +1.3%+0.2%0.0%
October 25, 2013October 25, 2013 ICUI Sale $769,731 +1.9%−1.1%−1.8%
October 25, 2013October 24, 2013 ICUI Sale $4,080,975 +1.9%−1.1%−4.5%
August 6, 2012August 3, 2012 ICUI Sale $266,950 +9.3%+10.1%+7.8%
April 24, 2012April 24, 2012 ICUI Sale $245,000 +5.8%+0.7%+2.3%
April 24, 2012April 23, 2012 ICUI Sale $242,500 +5.8%+0.7%+5.2%
February 17, 2012February 17, 2012 ICUI Sale $23,454 +14.6%+7.1%+9.7%
November 30, 2011November 30, 2011 ICUI Sale $217,350 −6.7%+20.4%+19.1%
November 22, 2011November 22, 2011 ICUI Sale $210,000 −6.4%+21.7%+21.4%
April 25, 2011April 21, 2011 ICUI Sale $23,317 −6.9%+7.5%+3.4%
April 25, 2011February 11, 2011 ICUI Sale $456,700 −6.9%+7.5%+7.3%
November 15, 2010November 15, 2010 ICUI Sale $37,000 +3.1%+11.4%+8.2%
October 28, 2010October 27, 2010 ICUI Sale $37,263 −2.2%−1.4%−0.7%
October 25, 2010October 25, 2010 ICUI Sale $37,360 −5.0%−1.2%−1.2%
August 24, 2010August 24, 2010 ICUI Sale $10,256 −14.7%−6.2%−4.9%
July 23, 2010July 23, 2010 ICUI Sale $37,000 −9.2%−12.1%−9.9%
February 18, 2010February 18, 2010 ICUI Sale $18,578 −3.1%−2.7%−5.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Costello Richard A traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.